Skip to main content

Radiopharmaceuticals in the Management of Leptomeningeal Metastasis

  • Book
  • © 2022

Overview

  • Offers a comprehensive review of LM treatment using radionuclides
  • Includes updated scientific modeling and imaging algorithms
  • Written with direct experience from practicing nuclear physicians, neurologists, and oncologists

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (12 chapters)

Keywords

About this book

This book reviews the current clinical practice of leptomeningeal metastasis (LM) diagnosis and treatment, which is predominately by intrathecal chemotherapy and/or in combination with external beam radiotherapy.  LM is a refractory lethal complication of many human malignancies when neoplastic cells grow in the meninges. The use of penetrating emissions from radionuclides has the advantages of visualizing cerebrospinal fluid (CSF) flow and ablating meninges at shallow depths and has been used to diagnose CSF flow anomalies and to treat LM.  The scientific bases of using radionuclides inside human CSF and ablating LM will be discussed within the text, with results from established and completed clinical trials to explore optimal use of radionuclides to diagnose and treat LM. Many limitations of current practices of treating LM are also discussed, as well as potential avenues of overcoming these limitations. This book is an ideal guide for clinical researchers in the practice of treating leptomeningeal metastasis including radiologists, neurologists, oncologists and radiotherapists as well as their associates.

Editors and Affiliations

  • Dept of Nuclear Med, Unit No 1483, U Texas MD Anderson Cancer Ctr, Houston, USA

    Franklin C.L. Wong

About the editor

Franklin C.L. Wong, MD, PhD, JD is Professor of Nuclear Medicine and Neuro-Oncology at The University of Texas M. D. Anderson Cancer Center. He has published extensively, both original articles and book chapters, in nuclear medicine. 

Bibliographic Information

  • Book Title: Radiopharmaceuticals in the Management of Leptomeningeal Metastasis

  • Editors: Franklin C.L. Wong

  • DOI: https://doi.org/10.1007/978-3-031-14291-8

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Nature Switzerland AG 2022

  • Softcover ISBN: 978-3-031-14290-1Published: 13 November 2022

  • eBook ISBN: 978-3-031-14291-8Published: 12 November 2022

  • Edition Number: 1

  • Number of Pages: XI, 232

  • Topics: Nuclear Medicine, Oncology, Neurology

Publish with us